---
figid: PMC4259002__fonc-04-00350-g004
figlink: /pmc/articles/PMC4259002/figure/F4/
number: Figure 4
caption: Epidermal growth factor receptor pathway.
pmcid: PMC4259002
papertitle: 'EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment
  Beyond Progression.'
reftext: Katrijn Van Assche, et al. Front Oncol. 2014;4:350.
pmc_ranked_result_index: '105096'
pathway_score: 0.9112633
filename: fonc-04-00350-g004.jpg
figtitle: Epidermal growth factor receptor pathway
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4259002__fonc-04-00350-g004.html
  '@type': Dataset
  description: Epidermal growth factor receptor pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ARAF
  - MAPK3
  - JAK1
  - AKT2
  - MAPK1
  - EGF
  - TYK2
  - JAK2
  - AKT1
  - HBEGF
  - MAP2K1
  - EREG
  - BTC
  - STAT3
  - HRAS
  - TGFA
  - MAP2K2
  - AKT3
  - JAK3
  - RAF1
  - AREG
  - MTOR
  - BRAF
  - NRAS
  - EPGN
  - KRAS
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EREG
  entrez: '2069'
- word: EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: BTC
  entrez: '685'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: AREG
  entrez: '374'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EPGN
  entrez: '255324'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
